Jennifer K. Simpson
Overview
Jennifer K. Simpson received an average of $1M in total compensation, including $311K in salary, at Panbela Therapeutics between 2020 and 2021. Jennifer Simpson also received an average of $598K at Delcath Systems from 2013 to 2020.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
Panbela TherapeuticsPresident and Chief Executive Officer
Panbela TherapeuticsPresident and Chief Executive Officer
Delcath Systemsformer President/CEO
Delcath SystemsFormer President and Chief Executive Officer
Delcath SystemsPresident and Chief Executive Officer
Delcath SystemsPresident and Chief Executive Officer
Delcath SystemsPresident and Chief Executive Officer
Delcath SystemsPresident and Chief Executive Officer
Delcath SystemsPresident and Chief Executive Officer
Delcath SystemsInterim President and Chief Executive Officer
Source: SEC filings on April 29, 2022, April 15, 2021, April 7, 2021, November 2, 2020, August 19, 2019, May 5, 2017, June 21, 2016, and April 29, 2015.
Related executives
We found 20 more executives who work or worked at Panbela Therapeutics and Delcath Systems.
Gerard Michel
Delcath Systems
Chief Executive Officer
John Purpura
Delcath Systems
Chief Operating Officer
Johnny John
Delcath Systems
Senior Vice President, Clinical Development and Medical Affairs
Susan Horvath
Panbela Therapeutics
Chief Financial Officer
Michael Cullen
Panbela Therapeutics
Chairman
Christine Padula
Delcath Systems
Interim Principal Accounting Officer
Barbra Keck
Delcath Systems
Chief Financial Officer
Peter Graham
Delcath Systems
General Counsel
News
Panbela Therapeutics CEO Jennifer Simpson's 2021 pay jumps 372% to $1.2M
April 29, 2022
Panbela Therapeutics CEO Jennifer Simpson's 2020 pay jumps 62% to $1.7M
April 15, 2021
Delcath Systems CEO Gerard Michel's 2020 pay jumps 150% to $5.8M
April 7, 2021
Delcath Systems CEO Jennifer Simpson's 2019 pay jumps 97% to $1.1M
November 2, 2020
Delcath Systems CEO Jennifer Simpson's 2018 pay slips 11% to $542K
August 19, 2019